These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34107025)

  • 1. Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection.
    Pérez-Lago L; Martínez-Lozano H; Pajares Díaz JA; Díaz Gómez A; Machado M; Sola-Campoy PJ; Herranz M; Buenestado-Serrano S; Valerio M; Olmedo M; Andrés Zayas C; Comas I; González Candelas F; Bañares R; Catalán P; Muñoz P; García de Viedma D
    J Infect Dis; 2021 Sep; 224(5):788-792. PubMed ID: 34107025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Analysis of the Epidemiological Scenario around a SARS-CoV-2 Reinfection: Previous Infection Events and Subsequent Transmission.
    Pérez Lago L; Pérez Latorre L; Herranz M; Tejerina F; Sola-Campoy PJ; Sicilia J; Suárez-González J; Andrés-Zayas C; Chiner-Oms A; Jiménez-Serrano S; García-González N; Comas I; González-Candelas F; Martínez-Laperche C; Catalán P; Muñoz P; García de Viedma D;
    mSphere; 2021 Oct; 6(5):e0059621. PubMed ID: 34494886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A first probable case of SARS-CoV-2 reinfection in Colombia.
    Novoa W; Miller H; Mattar S; Faccini-Martínez ÁA; Rivero R; Serrano-Coll H
    Ann Clin Microbiol Antimicrob; 2021 Jan; 20(1):7. PubMed ID: 33435982
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of COVID-19 reinfection in the UK.
    West J; Everden S; Nikitas N
    Clin Med (Lond); 2021 Jan; 21(1):e52-e53. PubMed ID: 33303623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response variables and viral mutations impact on COVID-19 reinfection and relapse.
    Sanaie S; Golipour E; Shamekh A; Sadaie MR; Mahmoodpoor A; Yousefi M
    Int Immunopharmacol; 2021 Nov; 100():108108. PubMed ID: 34521025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.
    Ao Z; Li Y; Wei J; Jiang J; Wang X; Zhang P; Liu Y; Yu H; Zhu L; Wang X; Hu Q; Duan J; Hu W; Zhang X; Wu G; Guo S
    Clin Exp Med; 2021 Aug; 21(3):361-367. PubMed ID: 33543353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran.
    Salehi-Vaziri M; Jalali T; Farahmand B; Fotouhi F; Banifazl M; Pouriayevali MH; Sadat Larijani M; Afzali N; Ramezani A
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1713-1719. PubMed ID: 33738620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies.
    Brehm TT; Pfefferle S; von Possel R; Kobbe R; Nörz D; Schmiedel S; Grundhoff A; Olearo F; Emmerich P; Robitaille A; Günther T; Braun P; Andersen G; Knobloch JK; Addo MM; Lohse AW; Aepfelbacher M; Fischer N; Schulze Zur Wiesch J; Lütgehetmann M
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33921216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible Cases of SARS-CoV-2 Reinfection In Pekanbaru, Indonesia.
    Kemal RA; Anggraini D
    Acta Med Indones; 2022 Jan; 54(1):107-113. PubMed ID: 35398831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    Rani PR; Imran M; Lakshmi JV; Jolly B; Jain A; Surekha A; Senthivel V; Chandrasekhar P; Divakar MK; Srinivasulu D; Bhoyar RC; Vanaja PR; Scaria V; Sivasubbu S
    J Med Virol; 2021 Jul; 93(7):4163-4165. PubMed ID: 33818797
    [No Abstract]   [Full Text] [Related]  

  • 11. A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding?
    Tuan J; Spichler-Moffarah A; Ogbuagu O
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33542020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses.
    Salehi-Vaziri M; Omrani MD; Pouriayevali MH; Fotouhi F; Banifazl M; Farahmand B; Sadat Larijani M; Ahmadi Z; Fereydouni Z; Tavakoli M; Jalali T; Ramezani A
    Virus Res; 2021 Jul; 299():198421. PubMed ID: 33836204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.
    Klein J; Brito AF; Trubin P; Lu P; Wong P; Alpert T; Peña-Hernández MA; Haynes W; Kamath K; Liu F; Vogels CBF; Fauver JR; Lucas C; Oh J; Mao T; Silva J; Wyllie AL; Muenker MC; Casanovas-Massana A; Moore AJ; Petrone ME; Kalinich CC; Dela Cruz C; Farhadian S; Ring A; Shon J; Ko AI; Grubaugh ND; Israelow B; Iwasaki A; Azar MM;
    J Infect Dis; 2022 Feb; 225(3):374-384. PubMed ID: 34718647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
    Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J
    Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.
    Tang CY; Wang Y; McElroy JA; Li T; Hammer R; Ritter D; Lidl GM; Webby R; Hang J; Wan XF
    J Med Virol; 2021 Oct; 93(10):5700-5703. PubMed ID: 34170528
    [No Abstract]   [Full Text] [Related]  

  • 16. Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy.
    Ibrahim M; Vegel A; Niu A; Panse K; Chen R; Safah H; Socola F; Luk A; Saba NS
    Leuk Res; 2021 Feb; 101():106514. PubMed ID: 33524639
    [No Abstract]   [Full Text] [Related]  

  • 17. A useful case for comparison, and a new definition of disease-free status.
    Jolobe OMP
    Am J Emerg Med; 2021 Aug; 46():746. PubMed ID: 33036852
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 reinfection: a rapid systematic review of case reports and case series.
    Wang J; Kaperak C; Sato T; Sakuraba A
    J Investig Med; 2021 Aug; 69(6):1253-1255. PubMed ID: 34006572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity after recovery from SARS-CoV-2 infection.
    Kojima N; Klausner JD
    Lancet Infect Dis; 2022 Jan; 22(1):12-14. PubMed ID: 34762853
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia.
    Scutari R; Fox V; De Ioris MA; Fini V; Granaglia A; Costabile V; Colagrossi L; Russo C; Mastronuzzi A; Locatelli F; Perno CF; Alteri C
    BMC Infect Dis; 2023 Mar; 23(1):133. PubMed ID: 36882724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.